Background: The number of bariatric procedures is rapidly growing as the prevalence of obesity in the USA is increasing. Such procedures are not without complications, and those affecting the nervous system are often disabling and irreversible. We now describe our experience with these complications and review the pertinent literature. Methods: We describe 26 patients with major neurologic conditions that seemed causally related to bariatric surgery encountered in the neurology service of a tertiary referral university medical center over a decade. Results: The neurologic complications affected most regions of the nervous system: encephalopathy, optic neuropathy, myelopathy, polyradiculoneuropathy, and polyneuropathy. Myelopathy was the most frequent and disabling problem; symptoms began about a decade after surgery. Encephalopathy and polyradiculoneuropathy were acute and early complications. Except for vitamin B 12 and copper deficiencies in patients with myelopathy, we could not correlate specific nutritional deficiencies to the neurologic complications. All patients had multiple nutritional deficiencies, but their correction did not often yield dramatic results. The best result was achieved in one patient after surgical revision to reduce the bypassed jejunum. Conclusions: A wide spectrum of serious neurologic conditions may follow bariatric surgery. These complications may occur acutely or decades later.
Obesity in the United States is reaching pandemic proportions with more than 63 million adult Americans with obesity, defined as body mass index (BMI) of Ն30 and 10.5 million with morbid obesity (BMI Ն 40) based on the 2000 US Census. 1 The impact of this pandemic on our society is huge because of associated morbidity and mortality. The annual obesity-attributable medical expenditures were estimated at $75 billion in 2003. 2 Medical treatment of obesity does not often achieve its long-term goals. In contrast, surgical treatment is soaring in popularity because of dramatic and durable results. In 2003, about 103,000 bariatric surgeries were performed in the United States, up by over fourfold from 1998. 3 This trend continues, encouraged by news media attention fueling the perception that bariatric surgery is an "easy fix" for a complicated problem.
Bariatric surgery undoubtedly causes rapid, considerable, and sustained weight loss because of restricted food intake combined with intestinal malabsorption. 4 In the 1980s, the Roux-en-Y procedure (gastrojejunal bypass with gastric restriction) became the most frequently performed bariatric surgical procedure. 5 It has lower morbidity and mortality rates than other bypass operations such as jejunocolic and jejunoileal bypass, and the weight loss is greater than after other gastric restrictive operations. 5 Yet, the Roux-en-Y and similar bariatric surgical procedures are not without complications. 6, 7 Chief among the nonsurgical complications are neurologic, often disabling and irreversible. 8, 9 One article estimated the neurologic complications of bariatric surgery, mostly the Roux-en-Y procedure, at 5%. 10 A more recent retrospective study of peripheral neuropathy after bariatric surgery found a 16% prevalence, but the authors included minor mononeuropathies such as meralgia paresthetica and carpal tunnel syndrome. 11 We now describe 26 patients that we encountered with major and disabling neurologic conditions attributed to bariatric surgery, and compare our experience with the literature. We previously presented a preliminary report of our findings. 12 METHODS Subjects. Between 1993 and 2004, we in the Department of Neurology at the University of Arkansas, a tertiary care institution, encountered 157 patients with neurologic conditions who gave history of bariatric surgery. In most, we did not believe there was a definite causal relationship between the neurologic condition and bariatric surgery. Examples included traumatic myelopathy, alcoholic and uremic polyneuropathies, migraine, depression, myasthenia gravis, multiple sclerosis, Parkinson disease, and degenerative spinal radiculopathies. We also excluded neurologic conditions that are often associated with obesity or rapid weight loss, such as sleep apnea, carpal tunnel syndrome, peroneal neuropathy, and meralgia paresthetica. After these exclusions, we were left with 26 patients with neurologic conditions that we believed were causally related to bariatric surgery based on clinical judgment. We reviewed the medical records of all patients and extracted the appropriate information, which included history, examination, neuroimaging, and clinical laboratory and neurophysiology findings. All patients had Roux-en-Y procedure. Because of variations in presentations and the different approaches of the neurologists caring for these patients, there was no uniformity in the manner by which the patients were studied and treated. Only two patients had their surgery at our institution, and the rest were performed by community surgeons, some of whose practices were focused on bariatric surgery. We have no information concerning the number of bariatric operations that were performed in our community over the duration of our study, and therefore the prevalence of neurologic complications can not be estimated. Presented data are means Ϯ SD. The study was approved by our institutional review board.
Literature review. We searched the MEDLINE database from 1966 through 2006 by combining the search terms "bariatric surgery" or "gastric bypass" or "gastroplasty" and "postoperative complications" or "encephalopathy" or "optic nerve diseases" or "spinal cord diseases" or "polyradiculopathy" or "polyneuropathy" or "muscular disease." English language article titles and abstracts were screened and the appropriate articles reviewed. Additional articles cited by original references were also reviewed. Subjects were excluded when surgery was performed for reasons other then obesity. Subjects with mononeuropathy, rhabdomyolisis, and night blindness were also excluded. The resultant 139 subjects culled from the literature 10, 11, were grouped into categories in a manner similar to our patients. Unlike our patients who all had the Rouxen-Y procedure, various bariatric surgical procedures were used in the subjects reviewed.
RESULTS
The mean age of our patients was 42.2 Ϯ 9.0 years. There were 3 men and 23 women. Mean maximal weight loss was 61.1 Ϯ 29.5 kg (42% of initial weight) about 1 year after surgery. The interval between bariatric surgery and onset of neurologic symptoms ranged from 4 weeks to 18 years (mean 6.6 Ϯ 5.9 years). Two patients (nos. 6 and 23) had revision of operations because of weight regain. The second operation was done to decrease the remaining stomach pouch volume in one and in the other to lengthen the segment of bypassed ileum. In these patients, the interval from operation to neurologic symptoms was calculated from the time of the second surgery. None of the patients had prior neurologic symptoms.
The neurologic complications, based on the most disabling symptoms, spanned most regions of the nervous system from the cerebral cortex to the peripheral nerves. We grouped the patients into five diagnostic categories based on the anatomic location of the presumed major underlying pathology (table 1). Many of the patients had additional symptoms attributed to nervous system dysfunction in regions other than the assumed primary site.
Encephalopathy with acute polyradiculoneuropathy occurred in two women at 4 and 4 weeks after surgery, with no protracted vomiting but profound weight loss. They were confused, anxious, uncooperative, and incontinent of urine. One had auditory hallucinations. Both had severe painful myalgias and lower extremity weakness, worse proximally. They did not have ophthalmoplegia, nystagmus, or other cranial nerve abnormalities. Both had hyporeflexia in the arms and areflexia in the legs, with loss of proprioception and vibratory and pinprick sensation in the legs. They could not walk because of weakness, sensory ataxia, and pain. They had no specific laboratory or imaging abnormalities, and in one, serum thiamine was measured and found normal before multivitamin administration. On treatment with parenteral nutritional supplementation, including thiamine and increased caloric intake, mental status slowly recovered, but weakness and ataxia persisted during follow-up for 2 and 12 months.
Unilateral optic neuropathy occurred acutely 1.5 and 3 years after bariatric surgery in two women, nonsmokers, ages 48 and 25 years. Their only laboratory abnormality was low serum vitamin B 12 . Patient 4 was not taking vitamin B 12 supplements and Patient 3 stopped vitamin B 12 injections 5 months before symptom onset. Resumption of B 12 injections quickly improved vision in Patient 3. Patient 4 was treated with IV methylprednisolone, 1 g/day, for 5 days, on the assumption that she had multiple sclerosis, but without improvement. She was given B 12 injections 4 months after onset of symptoms with no improvement in visual acuity. Neither patient had relapsing-remitting neurologic events before symptom onset or follow-up (6 months and 3 years). Brain MRI of Patient 3 showed four deep white matter hyperintensities on fluid-attenuated inversion recovery sequences (figure 1) without contrast enhancement. She also had a high CSF IgG index of 0.95 (normal range 0.28 to 0.66), high CSF IgG synthesis rate (18.7 mg/day, normal range 0 to 8 mg/day), and positive oliogoclonal bands (OCB). This patient did not have new symptoms or new MRI lesions in the next 3 years. Patient 4 showed contrast enhancement of the symptomatic optic nerve on MRI, which resolved completely after 3 months. She had no other neuroimaging abnormalities. This patient also had increased CSF IgG index of 0.7 and positive OCB, but she also had low serum IgG.
Posterolateral myelopathy was found in 12 patients. Except for Patient 14, the neurologic problems started insidiously and were late (mean, 9.9 Ϯ 5.4 years; range 0.5 to 18 years). All patients had disabling gait ataxia, and 10 of 12 had spastic legs with hyperreflexia and Babinski signs. Limb weakness was noted in eight patients, and in four, the weakness was restricted to the legs. All patients had loss of proprioception and vibratory sensations in the legs. Five patients had stocking-glove loss of pinprick and temperature sensation. Eight patients had urinary urgency or incontinence.
Eight patients had head and spine MRI, which showed increased signal intensity on T2-weighted sequences in the posterolateral aspect of the spinal cord in one patient (figure 2). Three had small scattered T2-weighted signal abnormalities in the deep white matter of the brain. None of the four patients so tested had somatosensory evoked potentials abnormalities. Laboratory investigations showed decreased serum vitamin B 12 in 5 of 12 patients tested. One patient was given vitamin B 12 before the serum level was measured, but her condition progressed despite treatment. Five of eight patients tested had copper deficiency, and one had a high zinc level. Two of seven patients tested had low vitamin E levels. Many other nutritional deficiencies were also found in these patients, which are summarized in table 1 and appendix E-1. Five of 10 patients also had sensory and motor axonal distal polyneuropathy on electrophysiologic studies. Lumbar CSF analysis in eight patients gave normal results except that four had an elevated CSF/ serum IgG index and positive OCB. These patients had low serum IgG levels that may have contributed to the elevated index. One patient had a high myelin basic protein value without abnormal IgG index or OCB. Only one with abnormal CSF findings had nonspecific scattered deep white matter changes on T2-weighted MRI images of the brain. Two patients with positive IgG index and OCB had normal visual and brainstem auditory-evoked potentials.
All patients were treated to correct their nutritional deficiencies via oral or parenteral supplementation and were advised to increase caloric intake. The patients were followed after treatment for 3 Ϯ 2.2 years (range 1 to 7 years). All improved except two: One was stable and one worsened rapidly despite supplementation. However, most of them remained disabled, primarily because of gait ataxia. The patient who became worse despite 5 months of aggressive attempts to correct nutritional deficiencies (Patient 12) had a revision of the Roux-en-Y bypass so that the bypassed segment of jejunum was shortened by 70 cm. This patient also had a myopathy with myotonic electromyographic (EMG) discharges and evidence of axonal sensorimotor distal polyneuropathy. After surgical revision, the myop-athy resolved within 2 months, the posterolateral myelopathy improved after 6 months, and the polyneuropathy improved after 9 months. Before revision, she had spasticity, severe ataxia, distal dysesthesias, and generalized weakness, which were so severe that she could not turn in bed. After 5 months, she was no longer weak, and the ataxia disappeared after 16 months. Five years after revision, the patient's body weight increased from 61.4 to 80.9 kg (BMI ϭ 29).
Acute polyradiculoneuropathy, which superficially resembled Guillain-Barré syndrome (GBS), was observed in five patients. Two additional patients also had encephalopathy and were described above. Six patients developed the GBS-like syndrome within 3 months, and one patient had it 2 years after bariatric surgery. All patients reported pain in the feet or the lower back with paresthesias that started in the feet and ascended. The patients developed leg weakness within hours or days after the onset of paresthesias, and they became bedridden within a week. Weakness in most cases affected the legs and was associated with ataxia and areflexia. Vibration and proprioception sensations were severely affected in the legs. None had respiratory weakness or cranial nerve symptoms or signs.
Lumbar CSF studies in two patients were normal, including protein content. EMG and nerve conduction studies showed pure axonal, sensory, and motor polyradiculoneuropathy more severe in the legs. Quantitative autonomic tests revealed generalized sudomotor and cardiovagal dysfunction in two of three patients tested. All patients had no specific nutritional deficiency. Weight loss, however, was pronounced (mean 38.3 Ϯ 14.6 kg) and preceded symptoms. Patients were treated by increasing caloric intake, including parenteral nutrition, which was given to four patients. Five patients were followed for a mean of 4.6 years (range 1 to 12 years). They all improved and ultimately walked, although five continue to have moderate gait ataxia and distal leg weakness.
Polyneuropathy was the primary diagnosis in five patients. It was a late, slowly progressive complication of surgery (mean 9.0 Ϯ 4.8 years). Patients had distal, symmetric, and painful paresthesias. Only one had weakness (which was mild and distal), two had mild gait ataxia, two had orthostatic intolerance with syncope, and one had urinary urgency. All patients had stocking distribution loss of pinprick and temperature sensation, but only two had distal vibratory loss with decreased proprioception in toes. Three patients had vitamin B 12 deficiency, and one patient had vitamin B 1 deficiency (table 1). Three patients had EMG and nerve con- duction studies, and only one showed sensory and motor, axonal, and demyelinating distal polyneuropathy. Three patients had autonomic laboratory tests that revealed distal sudomotor dysfunction in all and orthostatic hypotension in two. Only two of the five improved with nutritional supplementation and the others remained stable. The nutritional deficiencies that were detected in our patients are enumerated in appendix E-1.
Reviewed subjects. The 139 subjects with neurologic complications following bariatric surgery reported in the literature were not too different from our patients. We summarize their neurologic findings in table 2. The main difference between our experience and that of the literature is that encephalopathy was more prevalent in the literature, whereas myelopathy was more prominent in our patients. Because encephalopathy usually occurs shortly after bariatric surgery while myelopathy is a later complication thereof, we believe that the difference reflects different patient population characteristics. Bariatric surgery is not frequently performed at our center, and thus we did not have the opportunity to see many patients with short-term complications. On the other hand, our tertiary referral center is more likely to attract patient with unexplained chronic problems, hence our relatively high proportion of posterolateral myelopathy. Also, all of our patients had Roux-en-Y procedure, whereas patients in the literature had a variety of bariatric surgical procedures. The other minor difference is that myopathy was reported as the only neurologic problem in two patients in the literature. 10, 68 DISCUSSION The prevalences of the neurologic complications of bariatric surgery in two prior large studies were estimated at 5 and 16%. 10, 11 However, both studies have drawbacks. First, more than one type of bariatric surgery was performed. Second, relatively minor neurologic complications were included, such as carpal tunnel syndrome and meralgia paresthetica. Third, one study considered only peripheral neuropathy. 11 Fourth, patients were followed for only 5 years after surgery in one study 10 and for unknown intervals in the other, 11 thereby missing many of the long-term grave neurologic sequelae. In addition to these studies, numerous single to several case reports altogether described 139 patients with neurologic complications of bariatric surgery (table 2) .
As is evident from our findings (table 1) and from the reported literature (table 2) , the neurologic complications of bariatric surgery involve most parts of the nervous system and frequently more than one. This division is not simply artificial because there seems to be characteristic syndromes. For example, encephalopathy and acute polyradiculoneuropathy occurred within weeks after surgery and were associated with severe weight loss. Such patients were thought to have Wernicke encephalopathy, which may have a wide spectrum of clinical presentations. Unlike the GBS, patients with acute polyradiculoneuropathy had axonal degeneration and did not have increased CSF protein. Their condition did not resemble critical illness neuropathy because there was no involvement of the phrenic nerves; the brunt of disease was mostly in the legs, and the patients had no sepsis or organ failure. In the encephalopathy and the acute polyradiculoneuropathy syndromes, thiamine deficiency should be emergently corrected and the patients given parenteral nutritional supplementation and increased caloric intake. In contradistinction, posterolateral myelopathy is a late complication that occurred in our patients on average 9 years after bariatric surgery. This syndrome was not as frequently described in the literature (table 2) possibly because of the large interval between symptoms and bariatric surgery. Of our 12 patients, 9 had either low serum vitamin B 12 or copper levels. Some responded to nutritional supplementation with specific attention to the deficient components, and some improved considerably. The others stabilized or improved slowly. Dramatic results were obtained only in the one patient who had surgical revision to shorten the bypassed intestine.
After bariatric surgery, patients show multiple biochemical nutritional abnormalities, 7 especially low serum iron, vitamin B 12 , vitamin D, and calcium levels. Many had low serum levels of vitamin E, copper, and zinc (tables 1 and 2; appendix E-1). Some also had low levels of serum proteins, particularly albumin. Except for low serum vitamin B 12 and copper in our patients with posterolateral myelopathy and thiamine in reported patients with acute encephalopathy and polyradiculoneuropathy, we could not correlate a specific nutritional deficiency to any particular neurologic syndromes.
Our treatment strategy was to correct all possible nutritional deficiencies, but this did not often produce dramatic neurologic improvement. Therefore, we suspect that the nutritional deficiencies after bariatric surgery denote general poor nutrition and deranged biochemical metabolic state. For instance, the most dramatic improvement was brought about by revision of the Roux-en-Y procedure by shortening the excluded jejunal loop by 0.7 m. This relatively minor revision resulted in marked improvement, although it was performed 8 years after the original operation and the patient had had symptoms for at least 1 year before revision. Surgical revision is probably the most effective manner of dealing with many of the severe complications of bariatric surgery. However, although we suggested revision of bariatric surgery to several patients, all but one refused because they dreaded obesity more than neurologic dysfunction.
Lumbar CSF was obtained from patients with optic neuropathy, posterolateral myelopathy, and acute polyradiculoneuropathy. Over all, the routine tests were not helpful, and in particular, there was no pleocytosis or increased protein concentration. In 6 of 11 patients, the "multiple sclerosis" panel showed increased IgG index and the presence of OCB. The abnormal IgG index may have been caused by a low serum IgG level, but that would not explain the presence of OCB. These patients had increased intrathecal IgG synthesis even though we did not believe they had multiple sclerosis, an opinion based mostly on clinical judgment and lack of MRI evidence of multiple sclerosis, or if they had imaging abnormalities, they had no changes in following years. Bariatric surgery may, in some manner, cause an increase in intrathecal IgG synthesis. Increased intrathecal IgG synthesis is not a specific feature of multiple sclerosis and occurs in other neurologic diseases. Whether such increased intrathecal IgG synthesis has a causal relationship to the neurologic manifestations in these patients remains unknown. One report invoked a role for inflammatory and immune mechanisms in polyneuropathy after bariatric surgery based on their finding of inflammatory infiltrates in sural nerve biopsy in three patients. 11 Physicians who care for patients after bariatric surgery should have a high index of awareness for the neurologic complications. Attention should be given to vitamin and mineral supplements to prevent some of these complications and to avoid severe and rapid weight loss. Many of our patients were not instructed to take vitamin supplements, and postoperative follow-up visits with medical nutritionists was not emphasized. Patients should be made aware of the symptoms that herald these neurologic complications, and physicians should attend to the wide-based nutritional deficiencies as early as possible after symptom onset with particular attention to vitamin B 12 and copper supplementation.
